


Thank you for your interest in ULTRAM® ER.
In order to print your ULTRAM® ER Extended–Savings Coupon, we need to know your age. Your age is required, but this information will not be stored. Please review our Privacy Policy.






On behalf of Biovail Corporation (manufacturer of ULTRAM® ER), PriCara®, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. is voluntarily recalling certain lots of ULTRAM® ER. For more information,
click here.
In order to print your ULTRAM® ER Extended–Savings Coupon, we need to know your age. Your age is required, but this information will not be stored. Please review our Privacy Policy.



ULTRAM® ER is used to manage moderate to moderately severe chronic pain in adults who need to be treated around the clock for their pain for an extended period of time.
IMPORTANT SAFETY INFORMATION
Do not take ULTRAM® ER if you have had an allergic reaction to tramadol, codeine, or other opioids in the past. Do not take ULTRAM®
ER in any situation where opioids should not be used, including acute
intoxication with alcohol, hypnotics, narcotics, centrally acting
analgesics, opioids, or psychotropic drugs. ULTRAM® ER may worsen central nervous system and respiratory depression.
Seizures have been reported in people taking tramadol, the active ingredient in ULTRAM®
ER, at recommended doses. The risk of seizures is increased with doses
of tramadol above the recommended range. Use of tramadol increases the
risk of seizures in people taking antidepressants, other opioids, or
other drugs that can cause seizures.
Risk of convulsions
may also increase in people with epilepsy, a history of seizures, or a
recognized risk for seizure (such as head trauma, metabolic disorders,
alcohol and drug withdrawal, and central nervous system infections).
People who are suicidal or have a history of addiction should not take ULTRAM® ER. Use of alcohol should be avoided when taking ULTRAM® ER. Do not take more than the recommended dose of ULTRAM® ER.
ULTRAM®
ER may be associated with a potentially life-threatening condition when
taken together with selective serotonin reuptake inhibitors (SSRIs),
serotonin norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase
inhibitors (MAOIs), tricyclic antidepressants (TCAs) (classes of drugs
for depression or other disorders), triptans, lithium, or St. John's
wort. Some common SSRIs are Paxil (paroxetine), Prozac/Sarafem (fluoxetine), and Zoloft (sertraline). Some common SNRIs are Cymbalta (duloxetine) and Effexor (venlafaxine). Some common triptans are Axert (almotriptan), Imitrex (sumatriptan), and Relpax (eletriptan).
Symptoms of Serotonin Syndrome can include mental-state changes such as
agitation, hallucinations, and coma. Symptoms can also include
autonomic instability (e.g. fast heartbeat, fluctuating blood pressure,
increased body temperature), neuromuscular aberrations (e.g. overactive
reflexes, incoordination), and/or gastrointestinal symptoms (e.g.
nausea, vomiting, diarrhea).
Serious and rarely fatal anaphylactic (allergic) reactions can occur, even if you have never taken tramadol.
Taking ULTRAM®
ER, alone or in combination with alcohol, or medications such as
tranquilizers, hypnotics, or other opioids, can cause respiratory
depression, seizures, overdose and possibly death. Taking certain
medications together can increase the risk of respiratory and central
nervous system depression. These medications may include alcohol,
opioids, anesthetic agents, narcotics, phenothiazines, tranquilizers,
or sedative hypnotics.
Before taking ULTRAM® ER, you should inform your doctor if you have been diagnosed with increased intracranial pressure or have had a head injury.
ULTRAM® ER may impair your ability to perform potentially hazardous tasks, such as driving a car or operating machinery.
Talk with your
doctor about all medications you are taking. These may include
antidepressants, tranquilizers, hypnotics, or other opioid pain
medicines. If you experience symptoms such as restlessness,
hallucinations, loss of coordination, fast heartbeat, rapid changes in
blood pressure, increased body temperature, overactive reflexes,
nausea, vomiting, or diarrhea, contact your doctor immediately.
Do not change your dose or stop taking ULTRAM® ER without talking with your doctor first as you may experience withdrawal symptoms.
ULTRAM® ER can be abused or cause dependence. ULTRAM®
ER tablets must be swallowed whole. Do not chew, crush, or split the
tablet before swallowing. This can lead to overdose and possible
serious injury including death. You should not use ULTRAM® ER if you have severe renal impairment.
The most common side effects reported with ULTRAM® ER were dizziness, nausea, constipation, headache, and drowsiness.
Tell your doctor
about all your medical conditions and if you are pregnant, think you
might be pregnant, or are trying to become pregnant.
Please talk to your healthcare professional for more information or if you have further questions about ULTRAM®
ER. You can also call the Ortho-McNeil-Janssen Scientific Affairs, LLC,
Customer Communications Center at 1-800-526-7736 for more information.
In addition, please visit www.ultram-er.com for full Prescribing Information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Please see full US Prescribing Information.
Paxil and Imitrex are registered trademarks of GlaxoSmithKline.
Prozac/Sarafem and Cymbalta are registered trademarks of Eli Lilly.
Zoloft/Relpax are registered trademarks of Pfizer, Inc. Effexor is a
registered trademark of Wyeth. Axert is a registered trademark of
Almirall Prodesfarma.
© Ortho-McNeil-Janssen Pharmaceuticals, Inc. 2008-2010. All rights
reserved. Your use of the information on this site is subject to the
terms of our
This site is published by
PriCara® recognizes that the Internet is a global communications
medium; however, laws, regulatory requirements and medical practices
for pharmaceutical products vary from country to country. The
prescribing information included here may not be appropriate for use
outside of the United States. Capitalized product names are trademarks
of
This page was
last modified on
May 28 2010 at 16:15:40 EDT.